28 results
8-K
EX-99.1
ANNX
Annexon Inc
4 Mar 24
Regulation FD Disclosure
5:25pm
of ANX005 regarding DATA PACKAGE IN ODD APPLICATION muscle weakness recovery and need for ventilation as compared to IVIg. Given the modest response
8-K
EX-1.1
ANNX
Annexon Inc
21 Dec 23
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
4:09pm
), the Company had prepared the following information (collectively with the pricing information set forth on Annex A, the “Pricing Disclosure Package … to offer the Offered Securities on the terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may
DEF 14A
4q8 fa5uo9rw
22 Apr 21
Definitive proxy
4:06pm
10-K
moprhaiw6ur6a
25 Mar 21
Annual report
7:16am
8-K
EX-10.1
366pi1fgujjkyb3lip9
22 Dec 20
Entry into a Material Definitive Agreement
4:05pm
10-Q
0aevetc
8 Sep 20
Quarterly report
5:18pm
424B4
ofvcd
24 Jul 20
Prospectus supplement with pricing info
5:15pm
S-1/A
j7d6cum
20 Jul 20
IPO registration (amended)
6:07am
S-1/A
EX-1.1
lp6j djxzpnx7a
20 Jul 20
IPO registration (amended)
6:07am